Search clinical trials for: HCV 796

Total 8051 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men

Healthy

Japan
Wyeth is now a wholly owned subsidiary of Pfizer
ViroPharma

Completed

Study to Evaluate the Effects of Age & Gender on PK, Safety & Tolerability of HCV-796 Administered to Healthy Subjects

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer
ViroPharma

Completed

Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

Hepatic Insufficiency | Hepatitis C

United States
Assistance Publique - Hôpitaux de Paris
Gilead Sciences

Terminated

HCV, HBV, HIV Testing During Consultation With Anesthesiologist (SAHARA)

Hiv | HBV | HCV

France
Hasselt University
University Ghent

Completed

HBV/HCV/HIV in Belgian Prisons

HIV Infections | Hepatitis B | Hepatitis C

Belgium
Nantes University Hospital

Completed

Study on the Prevalence of Hepatitis C In a psychiatRic Population (SaPHIR)

Hepatitis C

France
Boehringer Ingelheim

Completed

BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis

Psoriasis
Fundacion para la Investigacion Biomedica del Hospital...
Instituto de Salud Carlos III

Completed

Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03) (DRIVE)

HIV Infection | HCV Coinfection

Spain
California State University, Long Beach
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Science Aspects of Rapid Test Acceptance (BSARTA)

Hepatitis B | Hepatitis C | HIV | Syphilis

United States
Boehringer Ingelheim

Terminated

Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets in Patients With Active Rheumatoid Arthritis

Arthritis, Rheumatoid
Boehringer Ingelheim

Completed

Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered to Healthy Human Subjects

Healthy
Boehringer Ingelheim

Completed

Effect of Single Oral Dose BIRB 796 BS on Endotoxin-induced Inflammatory Responses in Healthy Human Subjects

Healthy
Boehringer Ingelheim

Terminated

Dose Finding Study of BIRB 796 BS in Patients With Moderate to Severe Crohn's Disease

Crohn Disease
Boehringer Ingelheim

Completed

Excretion Balance of 14c-radiolabeled BIRB 796 BS in Normal Male Subjects

Healthy
Boehringer Ingelheim

Completed

Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered Twice Daily Orally to Healthy Human Subjects

Healthy
Boehringer Ingelheim

Completed

Efficacy and Safety of Different Doses of BIRB 796 BS in Patients With Active Rheumatoid Arthritis

Arthritis, Rheumatoid
New York City Health and Hospitals Corporation

Completed

Integrating HIV and Hepatitis C Screening in an Urban Emergency Department

Hepatitis C | HIV/AIDS | Hiv | HCV Coinfection | HIV/AIDS and Infections

United States
Johns Hopkins Bloomberg School of Public Health
National Institute on Drug Abuse (NIDA)

Recruiting

A Setting Focus Overdose Prevention Intervention (Oasis)

HIV Infections | Drug Overdose | HCV

United States
Hospital Universitario Infanta Leonor

Completed

Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid ((UMC))

HIV Infections | Drug Use | HCV Infection | HBV (Hepatitis B Virus) | Viral Hepatitis

Spain
Boehringer Ingelheim

Completed

Safety, Pharmacokinetics and Pharmacodynamics of BIRB 796 BS Tablets Administered to Healthy Human Subjects

Healthy
National Institutes of Health Clinical Center (CC)

Completed

Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV

HIV Infection | Hepatitis C

United States
Boehringer Ingelheim

Completed

Safety, Pharmacokinetics and Pharmacodynamics of Single Rising Doses Oral BIRB 796 BS in Healthy Human Subjects

Healthy
Imam Abdulrahman Bin Faisal University

Completed

Pressure-controlled vs Volume Controlled Ventilation on RV Function During OLV

Lung Diseases

Saudi Arabia
Centre hospitalier de l'Université de Montréal...
Merck Sharp & Dohme LLC; Gilead Sciences; Ministere de la Sante et des Services...

Completed

Universal HIV Screening and Targeted HCV Screening in Emergency Department

Hepatitis C | Hiv

Canada
CHU de Reims

Completed

Interest of Routine Screening for Hepatitis B and C in Patients Receiving Chemotherapy for Solid Tumors (HepScreen)

Solid Tumor

France
Takeda

Completed

Single-Dose Phase 1 Study of TAK-792

Healthy Male Adults Participants

Japan
Columbia University
National Institute on Drug Abuse (NIDA); New York University; Beth Israel Medical...

Completed

A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results (iKnow2 Project)

Substance-related Disorders

United States
Hallym University Medical Center

Unknown

Comparison of Three Modes of Ventilation During Robot-assisted Hysterectomy in Trendelenburg Position

Anesthesia

Korea, Republic of
Shanghai Zhongshan Hospital

Completed

Comparison of Different Ventilation Mode During One-lung Ventilation

Ventilator-Induced Lung Injury | Thoracic Surgery | One Lung Ventilation

China
Ariston Pharmaceuticals, Inc.

Unknown

Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine

Migraine | Migraine Disorders | Migraine Headache | Migraine Without Aura | Migraine With Aura

Finland, Netherlands, United Kingdom
Wyeth is now a wholly owned subsidiary of Pfizer
ViroPharma

Completed

A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder Subjects

Hepatitis C

United States, Puerto Rico
Alios Biopharma Inc.

Completed

A Study to Assess the PK of AL-794 Formulations in Healthy Subjects

Influenza

United Kingdom
Wyeth is now a wholly owned subsidiary of Pfizer
ViroPharma

Completed

Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between HCV-796 and Desipramine

Healthy

United States
Kaneq Bioscience Limited

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of KQ-791

Insulin Resistance | Healthy Volunteers

Canada
Johns Hopkins University
National Institute of Nursing Research (NINR)

Completed

The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling

HIV Infection

United States
Syneos Health
SynerK Pharmatech (Suzhou) Limited

Recruiting

Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol

Elevated Low-Density Lipoprotein Cholesterol

Australia
University of North Carolina, Chapel Hill
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Innovations in HIV Testing (TI)

Human Immunodeficiency Virus

South Africa
MedMira Laboratories Inc.

Withdrawn

Rapid Diagnostics for HIV and Hepatitis

HIV Infections | Hepatitis B Infections | Hepatitis C Infections

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

HCV-796 and Midazolam Drug Interaction Study in Healthy Subjects

Healthy

United States
Hologic Deutschland GmbH
University Hospital Tuebingen

Completed

Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

Human Papilloma Virus Infection
GlaxoSmithKline

Recruiting

Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks

Gastroenteritis

China
Seoul National University Bundang Hospital

Unknown

Pressure-controlled Versus Volume-controlled Ventilation During Protective One Lung Ventilation

Arterial Oxygenation During Protective One Lung Ventilation

Korea, Republic of
NodThera Limited

Recruiting

Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease

Cardiovascular Diseases

United States
Amgen

Active, not recruiting

A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

Non-squamous Non-small Cell Lung Cancer | Epithelial Ovarian Cancer | Claudin 6-positive Advanced/Metastatic Malignant Solid Tumors

United States, Australia, Switzerland
Herbert Lyerly

Terminated

A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies

Solid Tumor

United States
Pfizer

Completed

A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics

Diabetes Mellitus, Type 2

United States
Peking University
KAEDI

Not yet recruiting

NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor

Gastric Cancer | Pancreatic Cancer | Solid Tumor

China
jianming xu
KAEDI

Recruiting

NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors

Gastric Cancer | Pancreatic Cancer | Solid Tumor

China
MiNK Therapeutics

Completed

Evaluate the Safety of agenT-797 in Participants With Moderate to Severe Difficulty Breathing Secondary to SARS-CoV-2

Respiratory Distress Syndrome, Adult

United States
ArQule, Inc. (a wholly owned subsidiary of Merck...

Completed

Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations

Solid Tumor

United States, Italy

Search clinical trials for: HCV 796

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations